Form 8-K - Current report:
SEC Accession No. 0001651308-26-000008
Filing Date
2026-04-14
Accepted
2026-04-14 09:49:37
Documents
12
Period of Report
2026-04-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20260414.htm   iXBRL 8-K 37726
2 EX-99.1 a20260414formxfy2025staran.htm EX-99.1 43403
  Complete submission text file 0001651308-26-000008.txt   202509

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20260414.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20260414_lab.xml EX-101.LAB 21545
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20260414_pre.xml EX-101.PRE 12484
15 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20260414_htm.xml XML 2849
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 26859439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)